Home Tirzepatide Side effects Hair loss
Tirzepatide and Hair loss
Reported in a small percentage, higher at top doses — reported at around 5–6% at the highest studied dose in weight-management trials, with higher rates in some real-world reports.
Reported in a small percentage, higher at top doses of participants in the tirzepatide trial program reported hair loss — reported at around 5–6% at the highest studied dose in weight-management trials, with higher rates in some real-world reports.
The mechanism is generally telogen effluvium — a temporary shift of hair follicles into a resting phase triggered by rapid weight loss and reduced nutritional intake, rather than a direct toxic effect on the follicle. Typically begins two to four months after rapid weight loss starts and resolves over subsequent months as weight stabilises.
Frequencies are approximate ranges from the published trial program and differ by dose, population and how events were collected. They are not a prediction for any individual.
| Reported frequency | Reported in a small percentage, higher at top doses |
|---|---|
| Typical onset | Typically begins two to four months after rapid weight loss starts and resolves over subsequent months as weight stabilises. |
| Mechanism | The mechanism is generally telogen effluvium — a temporary shift of hair follicles into a resting phase triggered by rapid weight loss and reduced nutritional intake, rather than a direct toxic effect on the follicle. |
| Usually resolves | Variable — see below |
| Requires urgent review | Only if a red-flag symptom below is present |
Why tirzepatide causes hair loss
The mechanism is generally telogen effluvium — a temporary shift of hair follicles into a resting phase triggered by rapid weight loss and reduced nutritional intake, rather than a direct toxic effect on the follicle.
When hair loss starts and how long it lasts
Typically begins two to four months after rapid weight loss starts and resolves over subsequent months as weight stabilises.
How to manage hair loss on tirzepatide
- Slow the rate of loss if it exceeds roughly 1% of body weight per week
- Meet protein requirements consistently
- Ask about checking ferritin, vitamin D, zinc and thyroid function
- Avoid additional stressors on the hair such as tight styling and heat during the shedding phase
- Expect regrowth to lag resolution by several months
Hair loss: when to contact a clinician
Seek medical advice promptly if any of the following occurs:
- Patchy rather than diffuse loss, which suggests a different diagnosis
- Scalp inflammation, scaling or pain
- Hair loss with other systemic symptoms
Does hair loss mean the tirzepatide dose is wrong?
Not necessarily. Adverse effects on tirzepatide cluster in the days after a dose increase and typically settle as the gut adapts. The usual response to a poorly tolerated step is to hold the current strength for another four weeks rather than to stop treatment or to climb faster. That decision belongs to your prescriber.
Frequently asked questions
Is the hair loss permanent?
Telogen effluvium is characteristically temporary, with regrowth once the trigger resolves.
Does a lower dose prevent it?
The association is mainly with rate of weight loss rather than dose itself, so slowing the loss is the more direct lever.
People also ask about tirzepatide hair loss
What is tirzepatide hair loss?
Tirzepatide hair loss is covered in full on this page, with the clinical detail drawn from the tirzepatide prescribing information and the published SURMOUNT and SURPASS trial program, and any price figures drawn from our tracked dataset and dated to their last verification.
Does tirzepatide hair loss apply to compounded tirzepatide as well as Zepbound?
The molecule is the same, so the clinical content applies to both. What differs is regulatory status, dose metering and price: compounded preparations are not FDA-approved, arrive as a multi-dose vial you measure yourself, and cost a fraction of the brand routes.
How much does tirzepatide hair loss cost per month in 2026?
Compounded tirzepatide runs from $133 per month at the entry dose across the 21 compounded programs we track. At a 10 mg maintenance dose the cheapest tracked route is Oak Longevity at $199 per month, or about $2,388 for a first year on the standard escalation. Brand Zepbound through manufacturer self-pay sits well above that and pharmacy retail well above again. Verified 2026-08-05.
Is tirzepatide hair loss FDA-approved?
Brand tirzepatide (Zepbound and Mounjaro) is FDA-approved. Compounded tirzepatide is not: FDA does not approve compounded drugs and does not review them for safety, effectiveness or quality before they are marketed. The active molecule is the same; the regulatory review is not.
Sources
- US prescribing information for tirzepatide (Zepbound and Mounjaro), Eli Lilly and Company — dosing, storage, warnings and contraindications.
- SURMOUNT-1 — tirzepatide once weekly for the treatment of obesity, NCT04184622.
- SURPASS-2 — tirzepatide versus semaglutide 1 mg in type 2 diabetes, NCT03987919.
- Full source ledger — every primary source with a live link, what it supports, the date we read it, and the claims we deliberately do not source.